Published in Proc Natl Acad Sci U S A on December 17, 2004
Global regulation of H2A.Z localization by the INO80 chromatin-remodeling enzyme is essential for genome integrity. Cell (2011) 2.26
Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data. Breast Cancer Res (2006) 2.03
Every amino acid matters: essential contributions of histone variants to mammalian development and disease. Nat Rev Genet (2014) 1.62
The euchromatic and heterochromatic landscapes are shaped by antagonizing effects of transcription on H2A.Z deposition. PLoS Genet (2009) 1.52
Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer. Genome Res (2011) 1.39
A multilevel data integration resource for breast cancer study. BMC Syst Biol (2010) 1.32
Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model. Br J Cancer (2007) 1.23
Histone variants: emerging players in cancer biology. Cell Mol Life Sci (2013) 1.17
Expression of odontogenic ameloblast-associated protein (ODAM) in dental and other epithelial neoplasms. Mol Med (2008) 1.09
The many faces of C/EBPδ and their relevance for inflammation and cancer. Int J Biol Sci (2013) 1.06
DEAD-box helicase DP103 defines metastatic potential of human breast cancers. J Clin Invest (2014) 0.97
Mammalian adenylyl cyclase-associated protein 1 (CAP1) regulates cofilin function, the actin cytoskeleton, and cell adhesion. J Biol Chem (2013) 0.96
Expression and functionality of histone H2A variants in cancer. Oncotarget (2014) 0.95
Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer. Oncotarget (2013) 0.95
Low expression of novel lncRNA RP11-462C24.1 suggests a biomarker of poor prognosis in colorectal cancer. Med Oncol (2014) 0.93
The atypical CDK activator Spy1 regulates the intrinsic DNA damage response and is dependent upon p53 to inhibit apoptosis. Cell Cycle (2009) 0.90
Direct interactions with both p27 and Cdk2 regulate Spy1-mediated proliferation in vivo and in vitro. Cell Cycle (2016) 0.88
Profile of estrogen-responsive genes in an estrogen-specific mammary gland outgrowth model. Mol Reprod Dev (2009) 0.88
Stanniocalicin 2 suppresses breast cancer cell migration and invasion via the PKC/claudin-1-mediated signaling. PLoS One (2015) 0.82
Polymorphic genetic control of tumor invasion in a mouse model of pancreatic neuroendocrine carcinogenesis. Proc Natl Acad Sci U S A (2010) 0.82
In vivo functional requirement of the mouse Ifitm1 gene for germ cell development, interferon mediated immune response and somitogenesis. PLoS One (2012) 0.79
Follicular dendritic cell secreted protein FDC-SP controls IgA production. Mucosal Immunol (2014) 0.79
Identification and characterization of PNRC splicing variants. Gene (2008) 0.79
PNRC accumulates in the nucleolus by interaction with B23/nucleophosmin via its nucleolar localization sequence. Biochim Biophys Acta (2010) 0.78
The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer. BMC Cancer (2012) 0.78
The cyclin-like protein, SPY1, regulates the ERα and ERK1/2 pathways promoting tamoxifen resistance. Oncotarget (2017) 0.75
TNFα Amplifies DNaseI Expression in Renal Tubular Cells while IL-1β Promotes Nuclear DNaseI Translocation in an Endonuclease-Inactive Form. PLoS One (2015) 0.75
Spy1 participates in the proliferation and apoptosis of epithelial ovarian cancer. J Mol Histol (2015) 0.75
Molecular portraits of human breast tumours. Nature (2000) 94.14
Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 71.36
Serial analysis of gene expression. Science (1995) 60.15
Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A (2003) 34.68
Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev (1996) 5.17
Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science (2003) 3.59
Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc Natl Acad Sci U S A (2002) 3.55
Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res (2003) 2.55
Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res (2004) 2.36
A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res (2001) 2.22
General statistics of stochastic process of gene expression in eukaryotic cells. Genetics (2002) 2.06
Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation. J Biol Chem (2003) 1.97
STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc Natl Acad Sci U S A (1999) 1.96
AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene (2004) 1.68
The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. Cancer Res (2002) 1.45
Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells. Oncogene (2003) 1.43
The role of protein tyrosine phosphatase 1B in Ras signaling. Proc Natl Acad Sci U S A (2004) 1.43
cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells. Oncogene (2003) 1.34
Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol (2004) 1.33
RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death. J Biol Chem (2002) 1.31
Cloning and characterization of the human activity-dependent neuroprotective protein. J Biol Chem (2001) 1.30
Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene. FASEB J (1995) 1.29
Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors. Cancer Res (2000) 1.28
Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2. J Cell Biol (2002) 1.24
Overexpression of profilin reduces the migration of invasive breast cancer cells. Cell Motil Cytoskeleton (2004) 1.16
eSAGE: managing and analysing data generated with serial analysis of gene expression (SAGE). Bioinformatics (2000) 1.15
Characterization of overlapping XAGE-1 transcripts encoding a cancer testis antigen expressed in lung, breast, and other types of cancers. Mol Cancer Ther (2002) 1.15
A novel human gene encoding HECT domain and RCC1-like repeats interacts with cyclins and is potentially regulated by the tumor suppressor proteins. Biochem Biophys Res Commun (1999) 1.10
Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis? FEBS Lett (2001) 1.09
Clik1: a novel kinase targeted to actin stress fibers by the CLP-36 PDZ-LIM protein. J Cell Sci (2002) 1.06
Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Lett (2001) 1.06
Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients. Int J Cancer (2000) 1.06
cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model. Lab Invest (2004) 1.05
Assignment1 of human putative tumor suppressor genes ST13 (alias SNC6) and ST14 (alias SNC19) to human chromosome bands 22q13 and 11q24-->q25 by in situ hybridization. Cytogenet Cell Genet (1998) 1.03
Expression of translationally controlled tumor protein mRNA in human colon cancer. Cancer Lett (2000) 1.01
Oncostatin M and leukemia inhibitory factor regulate the growth of normal human breast epithelial cells. Growth Factors (2001) 1.00
Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. Cancer Res (2003) 0.99
Autocrine transforming growth factor alpha provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth states. J Biol Chem (1998) 0.94
Spermatogonia-dependent expression of testicular genes in mice. Dev Biol (2002) 0.93
Identification of semaphorin3B as a direct target of p53. Neoplasia (2002) 0.91
Nonenzymatic extraction of cells from clinical tumor material for analysis of gene expression by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis (1993) 0.87
Restriction landmark genomic scanning of mouse liver tumors for gene amplification: overexpression of cyclin A2. Biochem Biophys Res Commun (2000) 0.78
Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A (2003) 14.01
Genetic Recombinations Leading to Production of Active Bacteriophage from Ultraviolet Inactivated Bacteriophage Particles. Genetics (1949) 10.43
The integrated state of viral DNA in SV40-transformed cells. Proc Natl Acad Sci U S A (1968) 8.38
An activity from mammalian cells that untwists superhelical DNA--a possible swivel for DNA replication (polyoma-ethidium bromide-mouse-embryo cells-dye binding assay). Proc Natl Acad Sci U S A (1972) 6.75
VIRUS-CELL INTERACTION WITH A TUMOR-PRODUCING VIRUS. Proc Natl Acad Sci U S A (1960) 5.46
Topoinhibition and serum requirement of transformed and untransformed cells. Nature (1970) 5.00
Regulation of transcription of the SV40 DNA in productively infected and in transformed cells. Proc Natl Acad Sci U S A (1968) 4.80
Viral DNA in polyoma- and SV40-transformed cell lines. Proc Natl Acad Sci U S A (1968) 4.24
Simian virus 40 T antigen binds to DNA. Proc Natl Acad Sci U S A (1974) 4.23
Induction of DNA synthesis by SV40. Proc Natl Acad Sci U S A (1966) 4.20
Production of SV40 virus in heterokaryons of transformed and susceptible cells. Proc Natl Acad Sci U S A (1967) 4.14
A temperature-sensitive mutant of simian virus 40 affecting transforming ability. Virology (1973) 4.11
Virus-specific proteins in the plasma membrane of cells lytically infected or transformed by pol-oma virus. Proc Natl Acad Sci U S A (1977) 3.68
A septin-based hierarchy of proteins required for localized deposition of chitin in the Saccharomyces cerevisiae cell wall. J Cell Biol (1997) 3.37
A turning point in cancer research: sequencing the human genome. Science (1986) 3.29
Characterization of polyoma virus T antigen. Proc Natl Acad Sci U S A (1977) 3.21
Partial V(D)J recombination activity leads to Omenn syndrome. Cell (1998) 3.18
Strand orientation of simian virus 40 transcription in productively infected cells. Proc Natl Acad Sci U S A (1972) 3.13
Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet (2000) 3.12
Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol (2002) 2.94
Isolation and characterization of temperature-sensitive mutants of simian virus 40. Virology (1972) 2.89
Do the four clades of the mtDNA haplogroup L2 evolve at different rates? Am J Hum Genet (2001) 2.88
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients. Ann Oncol (2008) 2.75
A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature (1987) 2.60
Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology (1991) 2.53
Conditions limiting multiplication of fibroblastic and epithelial cells in dense cultures. Nature (1973) 2.52
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood (2001) 2.50
State and organization of polyoma virus DNA sequences in transformed rat cell lines. J Virol (1979) 2.47
Nobel laureates' letter to President Bush. Washington Post (2001) 2.43
Polyoma virus proteins. 1. Multiple virion components. Virology (1971) 2.38
The FHIT gene 3p14.2 is abnormal in lung cancer. Cell (1996) 2.36
Life at depth: Photobacterium profundum genome sequence and expression analysis. Science (2005) 2.31
Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis. Ann Surg (2000) 2.27
Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol (1997) 2.19
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
Conditions determining initiation of DNA synthesis in 3T3 cells. Proc Natl Acad Sci U S A (1970) 2.15
DNA enzyme immunoassay: general method for detecting products of polymerase chain reaction. Clin Chem (1991) 2.12
Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol (1999) 2.11
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med (2001) 2.10
The replication of the ring-shaped DNA of polyoma virus. I. Identification of the replicative intermediate. Proc Natl Acad Sci U S A (1969) 2.06
Temperature-dependent surface changes in cells infected or transformed by a thermosensitive mutant of polyoma virus. Proc Natl Acad Sci U S A (1971) 2.05
Cell transformation by viruses. Science (1969) 2.04
Protein synthesis in Simian virus 40-infected monkey cells. Proc Natl Acad Sci U S A (1972) 2.01
Loss of simian virus 40 DNA-RNA hybrids from nitrocellulose membranes; implications for the study of virus--host DNA interactions. Proc Natl Acad Sci U S A (1972) 2.00
Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res (1998) 1.96
High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene (1989) 1.94
Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. J Nucl Med (2000) 1.93
Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem (2000) 1.88
Temperature-dependent properties of cells transformed by a thermosensitive mutant of polyoma virus. Proc Natl Acad Sci U S A (1970) 1.87
Exercise and weight loss in obese older adults with knee osteoarthritis: a preliminary study. J Am Geriatr Soc (2000) 1.80
Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development. J Natl Cancer Inst (1997) 1.79
Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet (2000) 1.71
Cross-reactivity between Thy-1 and a component of intermediate filaments demonstrated using a monoclonal antibody. Nature (1981) 1.68
Induction of cellular DNA synthesis by polyoma virus. 3. Induction in productively infected cells. Proc Natl Acad Sci U S A (1966) 1.65
Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer. Cell Mol Life Sci (2002) 1.65
Induction of growth in resting fibroblastic cell cultures by Ca++. Proc Natl Acad Sci U S A (1975) 1.65
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. Am J Pathol (1998) 1.64
Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet (2003) 1.62
Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST). Eur J Surg Oncol (2008) 1.62
Mammalian male and female germ cells express a germ cell-specific Y-Box protein, MSY2. Biol Reprod (1998) 1.60
A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma. Cancer Res (1996) 1.60
ZASP: a new Z-band alternatively spliced PDZ-motif protein. J Cell Biol (1999) 1.59
Evidence of H- and L-chains have co-operative roles in the iron-uptake mechanism of human ferritin. Biochem J (1992) 1.58
Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J Clin Invest (1993) 1.57
Induction of cellular DNA synthesis by polyoma virus. II. Increase in the rate of enzyme synthesis after infection with polyoma virus in mouse kidney cells. Virology (1965) 1.56
Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors. Breast Cancer Res Treat (1999) 1.54
Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects. Oncogene (2012) 1.53
Characterization of mec1 kinase-deficient mutants and of new hypomorphic mec1 alleles impairing subsets of the DNA damage response pathway. Mol Cell Biol (2001) 1.53
Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene (1992) 1.51
A comprehensive, high-resolution genomic transcript map of human skeletal muscle. Genome Res (1998) 1.51
Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. Mol Cell (2001) 1.50
Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res (1992) 1.50
Effect of imatinib on haematopoietic recovery following idarubicin exposure. Leukemia (2003) 1.43
The role of the L-chain in ferritin iron incorporation. Studies of homo and heteropolymers. J Mol Biol (1994) 1.43
Production and characterization of recombinant heteropolymers of human ferritin H and L chains. J Biol Chem (1993) 1.43
FATZ, a filamin-, actinin-, and telethonin-binding protein of the Z-disc of skeletal muscle. J Biol Chem (2000) 1.42
The reconstitution of cellular immunity after bone marrow transplantation in children. Haematologica (1992) 1.39
Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res (1997) 1.39
Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. J Immunol (1998) 1.37
Induction of cellular mRNA synthesis in BSC-1 cells infected by SV40. Virology (1968) 1.37
Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer (2001) 1.36
Viral particles in cervical condylomatous lesions. Tumori (1978) 1.36
Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma. Ann Oncol (2011) 1.36
Kinetics of early changes in phosphate and uridine transport and cyclic AMP levels stimulated by serum in density-inhibited 3T3 cells. Proc Natl Acad Sci U S A (1974) 1.35
The RAG1/RAG2 complex constitutes a 3' flap endonuclease: implications for junctional diversity in V(D)J and transpositional recombination. Mol Cell (1999) 1.35
Structural and functional basis for JAK3-deficient severe combined immunodeficiency. Blood (1997) 1.34
Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res (1995) 1.34
Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res (1995) 1.33
A novel zinc finger gene is fused to EWS in small round cell tumor. Oncogene (2000) 1.33
Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J Neurochem (2001) 1.33
N-terminal RAG1 frameshift mutations in Omenn's syndrome: internal methionine usage leads to partial V(D)J recombination activity and reveals a fundamental role in vivo for the N-terminal domains. Proc Natl Acad Sci U S A (2000) 1.32
Characterization of the replicative intermediates of polyoma virus. Virology (1974) 1.32
Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series. Ann Oncol (2009) 1.31
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study. Oral Oncol (2008) 1.31